Focus on COVID-19 | Jafron hemoperfusion becomes a powerful weapon against coronavirus!
Recently, seven nurses from the Hemodialysis Center of the Eastern Center of Wuhan University People's Hospital formed a "blood purification team" to effectively remove toxins and inflammatory mediators in patients.
Cytokine storm control strategies in treating COVID-19---Expert opinion from Prof. Claudio Ronco
A recently published article mentioned the need to prepare extracorporeal organ support in the ICU. The latest report confirms that COVID-19 has cytokine storm and emphasizes the importance of controlling inflammation.
Emergency Medical Assistance Signing Ceremony (Saudia Arabia-China)
In order to assist the republic of China on the epidemic event, the Kingdom of Saudi Arabia instructed the King Salman Humanitarian Aid and Relief Center to provide emergency medical assistance to China to fight the novel coronavirus. Jafron DX-10 blood purification machine and HA330 Hemoperfusion cartridge were included in the list of aided materials.
HA380/HA330 for 2019-nCoV Infection with ARDS
As we all know, recently an epidemic with 2019-nCoV has occurred in China. On Jan 31, 2020, the WHO declared the outbreak to be a public health emergency of international concern, which may cause some public panic. However, at the critical moment, all we need to do is maintaining a rational attitude and taking positive measures.
Fight the disease together!Jafron donated 7 million CNY to help with the novel coronavirus pneumonia epidemic prevention and control
On January 31th, Jafron Biomedical Co., Ltd. donated 2 million CNY in cash and 5 million CNY as medical supplies, with a total value of more than 7 million CNY to fight against the novel coronavirus pneumonia epidemic.
Jafron listed in the 2019 Hurun China top 500 private enterprises!
In Jan.9, Jafron is honored to be announced in the 2019 Hurun China top 500 private enterprises.
KHL Uremic hemoperfusion cartridge obtained medical device registration certificate
Dec.4，2019，KHL Uremic hemoperfusion cartridge obtained medical device registration certificate. It demonstrates the determination of Jafron to keep the health of all mankind innovation and enterprising.
Jafron won the award for “Best Shareholder Returns for Listed Companies”
At the "2019 Summit of GEM listed companies", the 10th anniversary event, Jafron won the award for “Best Shareholder Returns for Listed Companies”.
Jafron won the “2018 Golden Bull Award of most Valuable Investment "!
On Oct.31, 2019, organized by China securities journal, "2019 to improve the quality of listed companies peak forum and the 21st golden bull award of listed companies" was held in Beijing. Jafron won this award again.
Jafron Start-up meeting of observational trial on cytokine adsorption in Sepsis was held successfully in Berlin
During 2019, 9.28-10.2, 32nd ESICM LIVES was held in Berlin, Germany. More than 6000 doctors, anesthesiologists, nursing staffs and industry representatives attended, and over 300 Internationally renowned experts gave excellent academic reports.